デフォルト表紙
市場調査レポート
商品コード
1448314

プロテインチップの世界市場規模、シェア、成長分析、技術別、用途別、エンドユーザー別 - 産業予測2024~2031年

Global Protein Chip Market Size, Share, Growth Analysis, By Technology, By Application, By End user - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
プロテインチップの世界市場規模、シェア、成長分析、技術別、用途別、エンドユーザー別 - 産業予測2024~2031年
出版日: 2024年03月04日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のプロテインチップの市場規模は、2022年に7億1,306万米ドルとなり、2023年の7億6,654万米ドルから、2031年までには13億6,711万米ドルに成長し、予測期間中(2024~2031年)のCAGRは7.5%で成長する見通しです。

プロテオミクス研究、個別化医療、医薬品開発が、世界のプロテインチップ市場の変革期を牽引しています。タンパク質の相互作用や病気における重要性を理解することに注目が集まっているため、プロテインチップの需要が急増しています。これらのマイクロアレイはハイスループットのタンパク質分析を可能にし、科学者は一度に多くのタンパク質を調べることができます。市場には老舗企業と独創的な起業家が混在しているため、熾烈な競争が繰り広げられています。製品開発は技術の進歩に後押しされています。プロテインチップの用途は、バイオテクノロジー、臨床診断、医薬品、大学研究など、さまざまな分野で見られます。科学者たちは、タンパク質の複雑さと、それが多くの分野にどのように関係しているのかをまだ学んでいる最中であるため、プロテインチップの世界市場は全体として急速に拡大しています。今後数年間は、地域市場の変化、用途の成長、技術革新のすべてが市場の方向性に影響を与えると予想されます。

目次

エグゼクティブサマリー

  • 市場概要
  • 運命の輪

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模の推定
  • 市場の前提条件と制限

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

プロテインチップの世界市場:技術別

  • 市場概要
  • 分析用マイクロアレイ
  • 機能性タンパク質マイクロアレイ
  • 逆相タンパク質マイクロアレイ

プロテインチップの世界市場:用途別

  • 市場概要
  • 診断
  • プロテオミクス
  • 抗体の特性評価

プロテインチップの世界市場:エンドユーザー別

  • 市場概要
  • 病院・クリニック
  • 診断研究所
  • 学術調査機関
  • 製薬・バイオテクノロジー企業

プロテインチップの世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2021年)
  • 主な市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2021年)

主要企業プロファイル

  • Agilent Technologies(US)
  • PerkinElmer(US)
  • Bio-Rad Laboratories(US)
  • Thermo Fisher Scientific(US)
  • Sigma-Aldrich Corporation(US)
  • Illumina(US)
  • GE Healthcare(US)
  • Bruker Corporation(US)
  • Shimadzu Corporation(Japan)
  • Roche Diagnostics(Switzerland)
  • RayBiotech(US)
  • Gyros Protein Technologies(UK)
  • Innopsys(France)
  • Randox Laboratories(UK)
  • HORIBA, Ltd.(Japan)
  • CapitalBio Corporation(China)
  • Biotech Support Group(US)
  • Surmodics(US)
  • PerkinElmer(US)
  • Innova Biosciences(UK)
目次
Product Code: SQMIG35H2149

Global Protein Chip Market size was valued at USD 713.06 million in 2022 and is poised to grow from USD 766.54 million in 2023 to USD 1367.11 million by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

Proteomic research, personalized medicine, and drug development are driving a transformative era in the Global Protein Chip Market. The market is seeing a spike in demand for protein chips due to an increasing focus on comprehending protein interactions and their significance in illnesses. These microarrays make high-throughput protein analysis possible, allowing scientists to examine many proteins at once. There is fierce rivalry as a result of the market's mix of well-established firms and creative entrepreneurs. Product development is being encouraged by technological advancements. Applications for protein chips can be found in many fields, such as biotechnology, clinical diagnostics, medicines, and university research. Since scientists are still learning about the intricacies of proteins and how they relate to many fields, the global market for protein chips is expanding rapidly overall. In the upcoming years, it is expected that regional market changes, growing applications, and technological innovation will all influence the market's direction.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Protein Chip Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Protein Chip Market Segmental Analysis

The segmentation of the Global Protein Chip Market is based on end user, geography, technology, and application. It is separated into three categories based on technology: reverse phase protein microarrays, functional protein microarrays, and analytical microarrays. Proteomics, antibody characterisation, and diagnostics are included in the application segment. Hospitals and clinics, diagnostic labs, educational and research facilities, and pharmaceutical and biotechnological businesses are all included in the end user segment. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Protein Chip Market

There has been a noticeable change in lifestyle in the modern world, which has increased the incidence of cancer. This tendency has been influenced by elements including increased drug and alcohol misuse, tobacco usage, and alcohol intake. In addition, the prevailing sedentary lifestyle has led to a decrease in physical activity, which in turn has resulted in obesity-the main cause of many chronic lifestyle-related illnesses. The population's diabetes has been exacerbated by this sedentary lifestyle and the consumption of highly processed, sugary, and nutritionally lacking items from the many fast-food franchises. In addition, environmental factors such as air pollution have contributed to the rising cancer incidence rates.

Restraints in the Global Protein Chip Market

Since proteins are tiny and lose form and structure when removed from their native environment, they must be extracted from live creatures. This fragility makes it difficult to gather enough samples for examination, which presents problems for the market for protein chips. The main challenges are the lack of sample data and the analytical difficulties brought on by the small sample size. Because of their intrinsically microscopic character, analysis may miss significant protein expressions.

Market Trends of the Global Protein Chip Market

The need for protein chips has increased due to the trend toward customized medicine since they make it possible to analyze unique protein profiles and biomarkers. This makes it possible for medical professionals to customize care according to each patient's own molecular profile, which produces better results.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Protein Chip Market by Technology

  • Market Overview
  • Analytical microarrays
  • functional protein microarrays
  • and reverse phase protein microarrays

Global Protein Chip Market by Application

  • Market Overview
  • Diagnostics
  • proteomics
  • and antibody characterization

Global Protein Chip Market by End user

  • Market Overview
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • and Pharmaceutical & Biotechnological Companies

Global Protein Chip Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Agilent Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sigma-Aldrich Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RayBiotech (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gyros Protein Technologies (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Innopsys (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HORIBA, Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CapitalBio Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotech Support Group (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Surmodics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Innova Biosciences (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments